USSTOCK.TODAY
Pre-Market
Log in Sign up

Madrigal Pharmaceuticals Achieves First Profitable Quarter and Revenue Growth

Earnings Whispers · ·by G4L

MDGL
MDGL Madrigal Pharmaceuticals Inc
$432.60 -0.04%
View chart & analysis →
  1. 1Madrigal Pharmaceuticals recorded revenue of $431.27 million for the quarter.
  2. 2Madrigal Pharmaceuticals achieved a 267.9% surprise in diluted earnings per share compared to consensus estimates for the quarter.
  3. 3Management warned that profitability may not be sustained.

So what's the key point?

Madrigal Pharmaceuticals made a profit for the first time while increasing its revenue. The company earned much more money than experts expected, but there are warnings that this profitability might not continue.

Source Earnings Whispers · View original ↗

Related 3-line summaries

MediWound to Proceed with EscharEx Phase 3 Clinical Trials and Comparison with Madrigal Pharmaceuticals Case FinanceWire · Nov 3Madrigal Pharmaceuticals shares fall ahead of Q3 earnings release Earnings Whispers · Oct 27Paramount weighs selling CNN to clear $110B Warner acquisition GuruFocus.com +4 · Aug 14
Today's 5 AI picks, all free
Nothing hidden: past picks and how they did against the S&P 500.
See today's picks →
← Back to news